S0179 HCPCS code: Megestrol acetate, oral, 20 mg
S0179 is the HCPCS Level II code for megestrol acetate, oral, 20 mg. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.
Code details
| Field | Value |
|---|---|
| Section | S codes — Temporary national codes (non-Medicare) |
| Coverage code | I — Not payable by Medicare |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Z2 |
| Added | 2002-01-01 |
| Last action effective | 2002-01-01 |
What changed for S0179
- 2002-01-01: S0179 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code S0179?
S0179 is the HCPCS Level II code for megestrol acetate, oral, 20 mg. Short descriptor: "Megestrol 20 mg".
Does Medicare cover S0179?
Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.
Related S01 codes
- S0104 — Zidovudine, oral, 100 mg
- S0106 — Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
- S0108 — Mercaptopurine, oral, 50 mg
- S0109 — Methadone, oral, 5 mg
- S0117 — Tretinoin, topical, 5 grams
- S0119 — Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
- S0122 — Injection, menotropins, 75 iu
- S0126 — Injection, follitropin alfa, 75 iu
- S0128 — Injection, follitropin beta, 75 iu
- S0132 — Injection, ganirelix acetate, 250 mcg
- S0136 — Clozapine, 25 mg
- S0137 — Didanosine (ddi), 25 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under S0179
- Watch S0179 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for S0179
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.